Pretreatment With Rituximab Does Not Inhibit the Human Immune Response Against the Immunogenic Protein LMB-1

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-1160-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Recombinant Human Soluble CD4 Does Not Inhibit Immune Function in Cynomolgus Monkeys

Toxicologic Pathology
Forensic MedicineToxicologyPathologyCell BiologyMolecular Biology
1991English

Hepatitis B Virus Does Not Interfere With Innate Immune Responses in the Human Liver

Gastroenterology
HepatologyGastroenterology
2018English

Superinfection by Discordant Subtypes of HIV-1 Does Not Enhance the Neutralizing Antibody Response Against Autologous Virus

PLoS ONE
Multidisciplinary
2012English

The Pentapeptide QYNAD Does Not Inhibit Neuronal Network Activity

Aktuelle Neurologie
Neurology
2004English

How Does Stress Affect the Immune Response?

Cell & Developmental Biology
2012English

Characterization of the Antibody Response Against Plasmodium Falciparum Erythrocyte Membrane Protein 1 in Human Volunteers

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2007English

Humoral Immune Response Against Orally Administered Human Γ Globulin in the Carp

Fisheries Science
Aquatic Science
1998English

Tetranychus Urticae Mites Do Not Mount an Induced Immune Response Against Bacteria

Proceedings of the Royal Society B: Biological Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2017English

The Case Against Rituximab Maintenance

Nature Reviews Clinical Oncology
Oncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy